September 10th - 11th, 2019, Hilton (Amsterdam, Netherlands)

World Drug Safety Congress EU 2019

World Drug Safety Congress Europe was the first strategic pharmacovigilance event to unite a plethora of stakeholders in drug safety, from pharma and biotechs to regulators and patients.

The event continues to lead the way in moving the sector forward and has been running for over a decade. It is world renowned for its ability to connect key stakeholders and grow the industry. Join us and be part of the story!

 

 

EMPOWERING PATIENTS, PHYSICIANS,DRUG MANUFACTURERS AND CONSUMERS TO MAKE THE BEST DRUG SAFETY DECISIONS

 

The World Drug Safety Congress Europe will bring together key thought leaders and experts to explore these worldwide challenges. Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally. Make sure you are at the heart of the new drug safety era and participate in these critical discussions.

The meeting is set to bridge the gap between international regulatory bodies, industry professionals and academic representatives and will address how to drive pharmacovigilance operations forward into the 21st Century.

 

WORLD DRUG SAFETY FOCUSES ON:

  • How to plan for the wider international drug safety landscape 
  • How to work compliantly with a global regulatory overview and recent developments
  • How to establish a robust approach to safety in oncology and advanced therapies
  • How to harness Big Data and emerging technologies such as AI to support your safety measures 
  • How to manage drug safety operations in light of increasing complexities 
  • How to manage data and electronic submissions better 
  • How to effectively process the volume of cases 
  • How to operate within financial and logistical constraints
Read more:
https://www.terrapinn.com/conference/world-drug-safety-congress-europe/index.stm

Share this post

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedIn